  Designed to remove abnormal deposits of lipids, cellular debris and calcium deposits. Contains ginger, gugulipid, Curcumin and Bromelain. Bromelain reduces edema and breaks down fibrinogen. Curcumin has been demonstrated to reduce cholesterol uptake. Curcumin is a powerful anti-oxidant and anti-inflammatory. Inhibits platelet clumping and a strong anti-viral. CAUTION: Do not use curcumin if you have bilary tract dsfunction. Do not use on an empty stomach. Gugulipid lowers blood fat without the toxicity of cholesterol prescriptive medications. Gugulipid can lower triglyceride levels within a month. Ginger can inhibit the formation of abnormal blood clots. Ginger can increase ATP energy and cardiac output, inhibit platelet aggregation and improve circulation. Protocols: Arrythmia Atherosclerosis Cholesterol Reduction Congestive Heart Failure Disease Prevention Fibrinogen and Cardiovascular Disease Hypertension Medical Testing Description: To Prevent and Treat Cardiovascular Disease. Blood clots that form inside arteries are the leading cause of death in the Western world. Most heart attacks and strokes are caused by a blood clot that obstructs the flow of blood to a portion of the heart or brain. No blood flow means no life to heart or brain cells that are deprived of oxygen. Blood clots kill more than 600,000 Americans every year, yet conventional medicine has largely ignored well documented methods of reducing abnormal blood clot formation. Low-dose aspirin and certain nutrients provide partial protection against abnormal blood clots, but a newly identified clotting factor mandates that additional measures be taken to prevent heart attacks and strokes. Fibrinogen is a component of blood involved in the clotting process. High levels of fibrinogen predispose a person to coronary and cerebral artery disease, even when other known risk factors such as cholesterol are normal. High fibrinogen levels are at least as great a predictor of cardiovascular disease as any other known risk factor such as elevated LDL cholesterol, elevated triglycerides, high blood pressure, obesity, and diabetes. Fibrinogen levels are high in persons with a family history of heart disease. The predisposition to high fibrinogen levels is genetically inherited, which suggests that fibrinogen may be the genetic factor that causes familial heart disease. Exposure to cold increases fibrinogen levels by 23%. As a result, mortality from heart attack and stoke is higher in winter than in summer. Fibrinogen hinders blood flow and oxygen delivery by deforming red blood cells, causing red cell aggregation, and thickening the blood by increasing its viscosity-all of which leads to diminished circulation. Fibrinogen binds blood platelets together, thus initiating abnormal arterial blood clot formation. Fibrinogen is then converted to fibrin, which is the final step in the blood clotting process. Fibrinogen contributes to atherosclerosis by incorporating itself into arterial plaque. Fibrinogen and LDL cholesterol work together to help generate atherosclerotic plaques after fibrinogen initiates the process. Fibrinogen is converted into fibrin, which serves as a scaffold for LDL cholesterol in the formation of the atherosclerotic plaques that slowly block arteries. Platelet aggregation inhibitors reduce the risk that fibrinogen will cause an abnormal blood clot. Platelet aggregation inhibitors include aspirin, green tea, ginkgo, and vitamin E. However, for optimal protection against arterial blood clots, it makes sense to take agents that lower elevated fibrinogen levels directly. Both fish and olive oil have been shown to lower fibrinogen in humans with elevated fibrinogen levels. The daily amount of fish oil required to produce a fibrinogen-lowering effect in the published study was 6 grams, which is equal to about five capsules of Prolongevity's MEGA EPA fish oil concentrate capsules. Elevated homocysteine levels have been shown to block the natural breakdown of fibrinogen by inhibiting the production of tissue plasminogen activator. Trimethylglycine (TMG), folic acid and vitamin B6 reduce elevated homocysteine levels. One of the more interesting studies involves the use of Vitamin-c to break down excess fibrinogen. The government says that Americans need only 200 mg of Vitamin-c per day. This government report spurred widespread media ridicule of the use of Vitamin-c supplements in excess of 200 mg a day. In a report in the journal Atherosclerosis (Netherlands 1980, 35/2), heart disease patients were given either 1,000 mg or 2,000 mg a day of Vitamin-c to determine its effect on the breakdown of fibrinogen. At 1,000 mg a day, there was no detectable change in fibrinolytic activity or cholesterol, but at 2000 mg a day of Vitamin-c, there was a 27% decrease in the platelet aggregation index, a 12% reduction in total cholesterol, and a 45% increase in fibrinolytic (fibrinogen breakdown) activity! Again, the U.S. government is trying to defraud Americans into believing that they do not need vitamin supplements! In this case, Americans who choose to believe their government have an increased risk of dying of heart attacks and strokes. HERBAL CARDIOVASCULAR FORMULA: The HERBAL CARDIOVASCULAR FORMULA provides a variety of herbs, herbal extracts, and plant enzymes that have shown powerful therapeutic benefits in the prevention and treatment of cardiovascular diseases. These agents have specific mechanisms of action that go beyond standard nutrients and drugs. Here is a rundown of the most potent of these agents: Bromelain: Bromelain is a mixture of sulfur-containing proteolytic enzymes obtained from the stem of the pineapple plant. Bromelain breaks down fibrinogen and has been shown to be useful in treating cardiovascular disease. Dr. Hans Nieper is a German medical doctor, who has successfully used bromelain as a fibrinolytic agent for decades. Dr. Nieper has used high doses of bromelain, magnesium, and potassium on cardiovascular patients with great success. However, the FDA considers him an international criminal and has banned the importation of all "Nieper products" into the United States. Cardiovascular disease patients should test their fibrinogen levels to see if bromelain can lower serum fibrinogen to a safe level. Curcumin: Curcumin is the yellow pigment of turmeric. When rats were fed small doses of curcumin, their cholesterol levels fell to one-half those in rats not receiving curcumin. (Journal of Nutrition 100:1307-16 1970). Curcumin reduces cholesterol by interfering with intestinal cholesterol uptake, increasing the conversion of cholesterol into bile acids, and increasing the excretion of bile acids (International Journal of Vitamin Nutritional Research (61:364-9 1991). Curcumin prevents abnormal blood clot formation by interfering with the formation of thromboxanes, the promoters of platelet aggregation. Curcumin increases levels of prostacyclin, the body's natural inhibitor of abnormal platelet aggregation (Arzneim Forsh 36:715-7 1986). When 500 mg a day of curcumin was given to ten volunteers, there was a 29% increase in beneficial HDL cholesterol after only 7 days. Total cholesterol was reduced by 11.6% and lipid peroxidation was by 33% (Indian Journal of Physiology 36(4):273-275 1992). While FDA-approved cholesterol-lowering drugs can cause liver damage, curcumin's ability to help prevent cancer and inhibit dangerous viruses is well documented. Curcumin also has anti- inflammatory effects. Curcumin neutralizes dietary carcinogens and has been shown to inhibit cancer at the initiation, promotion, and progression stages of development. Curcumin is a potent antioxidant and has been shown to be an inhibitor of HIV replication via several different mechanisms. Unlike FDA-approved drugs, curcumin may protect against liver damage caused by viral hepatitis. CAUTION: Do not use curcumin if you have a biliary tract obstruction because curcumin increases the excretion of cholesterol-bile acids through the bile duct. High doses of curcumin on an empty stomach may cause stomach ulcers. Gugulipid: Gugulipid extract produces a blood-fat lowering effect with no side effects. In a study in the Journal of Associated Physicians-India (37(5):323-8, 1989), 125 patients who received gugulipid experienced an 11% decrease in total cholesterol and a 16.8% decrease in triglyceride levels within 3-4 weeks. Patients with elevated cholesterol responded better than patients with normal cholesterol. HDL cholesterol increased in 60% of the patients receiving gugulipid. In a placebo-controlled study, 205 patients received gugulipid (25 mg three times a day). Of the guglipid-treated patients, 70%-80% showed cholesterol reduction compared to virtually none in the placebo group Journal of Associated Physicians-India (37(5):328-8 1989). In another placebo controlled trial in 40 patients with high blood fat levels, serum cholesterol declined by 21.75% and triglycerides by 27.1% after three weeks of administration of gugulipid. After 16 weeks, HDL cholesterol increased by 35.8%. The placebo group did not achieve statistically significant results Indian Journal of Medical Research (87:356-60, 1988.) Ginger: Thromboxane initiates a cascade of events that can result in the formation of abnormal blood clots. Ginger is a potent inhibitor of thromboxane synthesis, just like aspirin is. Unlike aspirin, however, ginger also raises prostacylin, which inhibits abnormal platelet aggregation. Thus, ginger inhibits abnormal platelet aggregation by at least two mechanisms of action Medical Hypothesis (20:271, 1986). In a study in Prostaglandins Medicine (13:277, 1984), ginger inhibited platelet aggregation in vitro more effectively than onion or garlic. In the New England Journal of Medicine (303:756-7, 1980), it was reported that ginger completely inhibited arachidonate-induced platelet aggregation in platelet rich plasma that had been incubated for 1 to 60 minutes. Ethanol showed no effect. Ginger also increases the contractile strength of the heart. Scientists call ginger a "cardiotonic agent" because of its ability to increase ATP energy production in the heart and to enhance calcium pumping within heart cells that is required for optimal cardiac output. The herbs that best protect the cardiovascular system have been combined into a new HERBAL CARDIOVASCULAR FORMULA that provides the ideal potency of each pharmaceutical-grade herbal extract at a far lower price than buying these herbs separately. Each capsule of HERBAL CARDIOVASCULAR FORMULA contains: Curcumin (97% purity) 250 mg Bromelain (2000 gdu per gram) 250 mg Suggested use for this product is: Take one or two capsules 2 times per day. |
|
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies and meant for informational purposes only. Consult with your medical practitioner to determine the underlying cause of your symptoms. |